...
首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >Increased prevalence of low oligomeric state surfactant protein D with restricted lectin activity in bronchoalveolar lavage fluid from preterm infants
【24h】

Increased prevalence of low oligomeric state surfactant protein D with restricted lectin activity in bronchoalveolar lavage fluid from preterm infants

机译:早产儿支气管肺泡灌洗液中低聚表面活性剂D的低流行和凝集素活性受限制

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Surfactant protein D (SP-D) is a soluble oligomeric C-type lectin known to protect against lipopolysaccharide and ventilator-induced lung injury in preterm lambs. Here we assess the expression and functional status of SP-D in bronchoalveolar lavage fluid (BALF) from preterm infants at risk of chronic lung disease (CLD) of prematurity and term controls. This is the first systematic evaluation of SP-D function in any clinical cohort. Methods: SP-D was quantified in BALF from 28 ventilated preterm infants and five ventilated term infants. SP-D lectin activity was tested in a zymosan binding assay followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and western blot in BALF from the same infants. SP-D lectin activity was also tested towards maltose-agarose and mannan for selected BALF samples. Results: SP-D expression was lower on day 1 in those preterm infants who subsequently developed CLD but increased over the first 5 days of life in term and preterm neonates. The percentage of neonatal SP-D capable of binding zymosan rarely exceeded 50% in any BALF sample and was 3.5 times lower in preterm infants than term infants on day 1 of life. Similar binding defects were observed towards maltose-agarose and mannan. SDS-PAGE analysis revealed that zymosan-bound SP-D was more highly oligomerised (≥12-mers) than unbound SP-D, which was composed primarily of trimers and lower oligomeric forms. Conclusions: Substantial and functionally relevant variation in the expression and oligomeric distribution of SP-D exists between preterm and term neonatal lung secretions. This has implications for proposed SP-D replacement therapy in this population.
机译:背景:表面活性剂蛋白D(SP-D)是一种可溶性的寡聚C型凝集素,已知可预防脂多糖和呼吸机诱发的早产羔羊肺损伤。在这里,我们评估了早产儿和足月对照患慢性肺病(CLD)风险的早产儿支气管肺泡灌洗液(BALF)中SP-D的表达和功能状态。这是任何临床队列中对SP-D功能的首次系统评价。方法:对28名通气早产儿和5名通气早产儿的BALF中的SP-D进行定量。在同一个婴儿的BALF中,通过酵母聚糖结合测定,然后十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)和western印迹,对SP-D凝集素活性进行了测试。还针对选定的BALF样品对麦芽糖琼脂糖和甘露聚糖测试了SP-D凝集素活性。结果:在随后发生CLD的早产儿中,SP-D表达在第1天较低,但在足月和早产儿的生命的前5天中,SP-D表达增加。在任何BALF样品中,能够结合酵母聚糖的新生儿SP-D百分比很少超过生命的第一天,足月婴儿比足月婴儿低3.5倍,比足月婴儿低3.5倍。对于麦芽糖-琼脂糖和甘露聚糖观察到类似的结合缺陷。 SDS-PAGE分析表明,与主要由三聚体和低聚形式组成的未结合SP-D相比,与酵母聚糖结合的SP-D的寡聚化程度更高(≥12-mers)。结论:早产和足月新生儿肺分泌物之间存在SP-D的表达和寡聚分布的实质性和功能性相关变异。这暗示了该人群中提议的SP-D替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号